References
- Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. [Hepatic, arterial embolization in patients with malignant liver tumours (author's transl)]. Ann Radiol (Paris) 1974;17:593-603
- Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C. Transcatheter occlusion of abdominal tumors. Radiology 1976;120:539-545 https://doi.org/10.1148/120.3.539
- Katsumori T, Kasahara T. The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 2006;29:1077-1083 https://doi.org/10.1007/s00270-006-0059-y
- Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401 https://doi.org/10.1148/radiology.148.2.6306721
- Erinjeri JP, Salhab HM, Covey AM, Getrajdman GI, Brown KT. Arterial patency after repeated hepatic artery bland particle embolization. J Vasc Interv Radiol 2010;21:522-526 https://doi.org/10.1016/j.jvir.2009.12.390
- Sueyoshi E, Hayashida T, Sakamoto I, Uetani M. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2010;195:245-251 https://doi.org/10.2214/AJR.08.2301
- Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, et al. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 2008;26:206-212 https://doi.org/10.1007/s11604-007-0216-5
- Sahara S, Kawai N, Sato M, Tanaka T, Ikoma A, Nakata K, et al. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 2012;35:1363-1371 https://doi.org/10.1007/s00270-012-0352-x
- Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005;16:1661-1666 https://doi.org/10.1097/01.RVI.0000182160.26798.A2
- Katsumori T, Nakajima K, Mihara T, Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: midterm results. AJR Am J Roentgenol 2002;178:135-139 https://doi.org/10.2214/ajr.178.1.1780135
- Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 1994;81:1254-1269 https://doi.org/10.1002/bjs.1800810904
- Clowes AW. Intimal hyperplasia and graft failure. Cardiovasc Pathol 1993;2:179S-186S https://doi.org/10.1016/1054-8807(93)90058-A
- Liu MW, Roubin GS, King SB 3rd. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-1387 https://doi.org/10.1161/01.CIR.79.6.1374
- Carrel A, Guthrie CC. Anastomosis of blood vessels by the patching method and transplantation of the kidney. 1906 [classical article]. Yale J Biol Med 2001;74:243-247
- Waltham M, Harris J. Intimal hyperplasia: the nemesis of cardiovascular intervention. ANZ J Surg 2004;74:719-720 https://doi.org/10.1111/j.1445-1433.2004.03174.x
- Strauss BH, Wilson RA, van Houten R, van Suylen RJ, Murphy ES, Escaned J, et al. Late effects of locally delivered mitomycin C on formation of neointima and on vasomotor response to acetylcholine. Coron Artery Dis 1994;5:633-641 https://doi.org/10.1097/00019501-199407000-00012
- Richard HM 3rd, Silberzweig JE, Mitty HA, Lou WY, Ahn J, Cooper JM. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology 2000;214:775-779 https://doi.org/10.1148/radiology.214.3.r00mr31775
- Siskin GP, Dowling K, Virmani R, Jones R, Todd D. Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model. J Vasc Interv Radiol 2003;14:89-98 https://doi.org/10.1097/01.RVI.0000052296.26939.4c
- Stampfl S, Bellemann N, Stampfl U, Radeleff B, Lopez-Benitez R, Sommer CM, et al. Inflammation and recanalization of four different spherical embolization agents in the porcine kidney model. J Vasc Interv Radiol 2008;19:577-586 https://doi.org/10.1016/j.jvir.2008.01.011
- Kawai N, Sato M, Minamiguchi H, Ikoma A, Sanda H, Nakata K, et al. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles. J Vasc Interv Radiol 2013;24:1383-1390 https://doi.org/10.1016/j.jvir.2013.03.013
- Takasaka I, Kawai N, Sato M, Sahara S, Minamiguchi H, Nakai M, et al. A new soluble gelatin sponge for transcatheter hepatic arterial embolization. Cardiovasc Intervent Radiol 2010;33:1198-1204 https://doi.org/10.1007/s00270-010-9866-2
Cited by
- Indications for embolization in a French level 1 trauma center vol.153, pp.4, 2015, https://doi.org/10.1016/j.jviscsurg.2016.04.010
- Two cases of debulking surgery for lower limb diffuse plexiform neurofibroma with transcatheter arterial embolisation vol.55, pp.None, 2015, https://doi.org/10.1016/j.ijscr.2019.01.018
- Characterization of Calibrated Gelatin Sponge Particles in a Rabbit Renal Embolization Model vol.42, pp.8, 2015, https://doi.org/10.1007/s00270-019-02224-7
- Creation of an ex-vivo bovine kidney flow model for testing embolic agents: work in progress vol.4, pp.1, 2015, https://doi.org/10.1186/s42155-021-00210-0